Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early
detection are paramount to reducing cancer-related deaths and improving patient outcomes …

In this review, we discuss the interaction between cancer and markers of inflammation (such
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …

Background We evaluated pretreatment total lymphocyte count (TLC, marker of
immunosuppression), neutrophil-to-lymphocyte ratio (NLR, marker of inflammation), and …

The aim of this study is to investigate the diagnostic efficacy of neutrophil‐to‐lymphocyte
ratio (NLR), neutrophil‐to‐monocyte ratio (NMR), lymphocyte‐to‐monocyte ratio (LMR), and …

Background Systemic inflammation seems to be involved in the pathogenetic pathways of
colorectal cancer (CRC). Analytical markers that reflect the inflammatory status, such as …

Despite a multimodal radical treatment, mortality of advanced epithelial ovarian cancer
(AEOC) remains high. Host-related factors, such as systemic inflammatory response and its …

Background This study aimed at investigating the relationships between Platelet-
Lymphocyte ratio (PLR) and Neutrophil–Lymphocyte ratio (NLR) and their dynamic changes …

Objective To assess the utility of hematologic, inflammatory, and immunologic biomarkers for
differentiating between ovarian cancer and endometriosis. Methods Data were …

Background Peripheral blood inflammation indices, including the neutrophil-to-lymphocyte
ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index …

Objective: To evaluate the role of inflammatory markers for distinguishing malignant and
benign ovarian masses. Methods: Preoperative demographic, clinicopathologic, and …